期刊文献+

早期肾功能不全与心血管疾病 被引量:5

暂未订购
导出
出处 《临床荟萃》 CAS 2009年第22期2016-2018,共3页 Clinical Focus
  • 相关文献

参考文献1

二级参考文献7

  • 1Marenzi G, Lauri G, Guazzi M, et al. Cardiac and renal dysfunction in chronic heart failure: relation to neurohumoral activation and prognosis. Am J Med Sci,2001,321:359-366.
  • 2Marczewski KT, Krawczyk W, Ryszard, et al. Particular fractions of microproteinuria in patients with stabile angina pectoris and without a clinical nephropathy. Med Sci Monit,2000,6:93-95.
  • 3Pittrow D, Wittchen HU, Bramlage P, et al. Nephropathy: an overview for daily practice. Fortschr Med Orig, 2003,121 Suppl 1:39-44.
  • 4Taal MW, Brenner BM. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin Ⅱ antagonists. Kidney Int,2000,57:1803-1817.
  • 5Russo D, Pisani A, Balletta MM, et al. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis, 1999,33:851-856.
  • 6Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation,2000,102:203-210.
  • 7Smilde TD, Hillege HL, Navis G, et al. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. Am Heart J,2004,148:165-172.

共引文献41

同被引文献43

  • 1张远慧.中国最新高血压防治指南解读[J].新医学,2005,36(8):437-439. 被引量:39
  • 2赵秀丽,陈捷,崔艳丽,武峰,胡大一.中国14省市高血压现状的流行病学研究[J].中华医学杂志,2006,86(16):1148-1152. 被引量:291
  • 3Xiao Y,Peng C, Huang W, et al. Circulating Iibroblast growth factor 23 is associated with angiographic severity and extent of coronary artery disease[J]. PLoS One, 2013,8(8) :e72545.
  • 4Martin A,David V,Quarles LD. Regulation and function of the FGF23/klotho endocrine pathways[J]. Physiol Rev, 2012,92 (1) :131-155.
  • 5Rodriguez M, L6pez I, Mufioz J, et al. FGF23 and mineral metabolism,implications in CKD-MBD[J]. Nefrologia, 2012, 32(3) : 275-278.
  • 6Goetz R,Nakada Y, Hu MC, et al. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23- FGFR-Klotho complex formation[J]. Proc Natl Acad Sci U S A,2010,107(1) ,407-412.
  • 7Hu MC, Kuro-o M, Moe OW. Klotho and chronic kdney disease[J]. Contrib Nephrol, 2013,180 : 47-63.
  • 8Hu MC,Kuro-o M, Moe OW. The emerging role of Klotho in clinical nephrology[J]. Nephrol Dial Transplant, 2012,27 (7) : 2650-2657.
  • 9Goetz R, Mohammadi M. Exploring mechanisms of FGF signaling through the lens of structural biology[J]. Nat Rev Mol Cell Biol, 2013,14(3) : 166-180.
  • 10Hu MC, Shi M, Zhang J, et al. Klotho deficiency causes vascular calcification in chronic kidney disease[J]. J Am Soc Nephrol,2011,22(1) :124-136.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部